OBJECTIVE: To investigate the mode-of-action and patient experience of functionally optimized foot orthoses in patients with early rheumatoid arthritis (RA). METHODS: We conducted an investigation of 2 functionally optimized foot orthoses (selective laser sintering [SLS] and fused deposition modelling [FDM]) in 15 patients with RA of <2 years duration. The novel devices were optimized for 3 biomechanistic targets exploiting computer-aided design and additive manufacturing. A third standard device was used as the comparator (standard foot orthosis [SFO]). Foot and ankle biomechanical effects were compared. Adverse reactions, orthotic fit and comfort, and short-term symptom benefits were also monitored. RESULTS: Both FDM (P = 0.028) and SLS (P < 0.0001) orthoses significantly reduced peak rearfoot motion in comparison to shod. The average ankle internal moment was significantly decreased in the SFO (P = 0.010) and approached significance in the SLS (P = 0.052) orthosis. SFO, FDM, andSLS orthoses significantly increased the peak height of the medial foot arch between 3.6 to 4.4 mm (P < 0.001). Peak pressures in the medial (P = 0.018) and lateral forefoot (P = 0.022) regions of interest were significantly reduced for the SLS orthosis. SFO, FDM, andSLS orthoses significantly increased midfoot contact area (P < 0.001 for all conditions). In comparison to SFO, SLS and FDM orthoses provided equivalent or better patient experience. No adverse reactions were reported. CONCLUSION: Functional optimization is a feasible approach for orthoses prescription in early RA and has the potential to provide superior mode-of-action responses for biomechanical therapeutic targets compared to standard devices.
RCT Entities:
OBJECTIVE: To investigate the mode-of-action and patient experience of functionally optimized foot orthoses in patients with early rheumatoid arthritis (RA). METHODS: We conducted an investigation of 2 functionally optimized foot orthoses (selective laser sintering [SLS] and fused deposition modelling [FDM]) in 15 patients with RA of <2 years duration. The novel devices were optimized for 3 biomechanistic targets exploiting computer-aided design and additive manufacturing. A third standard device was used as the comparator (standard foot orthosis [SFO]). Foot and ankle biomechanical effects were compared. Adverse reactions, orthotic fit and comfort, and short-term symptom benefits were also monitored. RESULTS: Both FDM (P = 0.028) and SLS (P < 0.0001) orthoses significantly reduced peak rearfoot motion in comparison to shod. The average ankle internal moment was significantly decreased in the SFO (P = 0.010) and approached significance in the SLS (P = 0.052) orthosis. SFO, FDM, and SLS orthoses significantly increased the peak height of the medial foot arch between 3.6 to 4.4 mm (P < 0.001). Peak pressures in the medial (P = 0.018) and lateral forefoot (P = 0.022) regions of interest were significantly reduced for the SLS orthosis. SFO, FDM, and SLS orthoses significantly increased midfoot contact area (P < 0.001 for all conditions). In comparison to SFO, SLS and FDM orthoses provided equivalent or better patient experience. No adverse reactions were reported. CONCLUSION: Functional optimization is a feasible approach for orthoses prescription in early RA and has the potential to provide superior mode-of-action responses for biomechanical therapeutic targets compared to standard devices.
Authors: Gabriel Gijon-Nogueron; Laura Ramos-Petersen; Ana Belen Ortega-Avila; Jose Miguel Morales-Asencio; Silvia Garcia-Mayor Journal: Qual Life Res Date: 2018-06-19 Impact factor: 4.147
Authors: David T Felson; Anthony C Redmond; Graham J Chapman; Toby O Smith; David F Hamilton; Richard K Jones; Cathy A Holt; Michael J Callaghan; Deborah J Mason; Philip G Conaghan Journal: Rheumatology (Oxford) Date: 2015-09-10 Impact factor: 7.580
Authors: Kellie S Gallagher; Jon Godwin; Gordon J Hendry; Martijn Steultjens; Jim Woodburn Journal: J Foot Ankle Res Date: 2018-05-31 Impact factor: 2.303
Authors: Marloes Tenten-Diepenmaat; Joost Dekker; Martijn W Heymans; Leo D Roorda; Thea P M Vliet Vlieland; Marike van der Leeden Journal: J Foot Ankle Res Date: 2019-06-13 Impact factor: 2.303
Authors: Marloes Tenten-Diepenmaat; Joost Dekker; Jos W R Twisk; Elleke Huijbrechts; Leo D Roorda; Marike van der Leeden Journal: BMC Musculoskelet Disord Date: 2020-06-04 Impact factor: 2.362
Authors: Jorge Barrios-Muriel; Francisco Romero-Sánchez; Francisco Javier Alonso-Sánchez; David Rodríguez Salgado Journal: Materials (Basel) Date: 2020-01-09 Impact factor: 3.623
Authors: María Reina-Bueno; María Del Carmen Vázquez-Bautista; Inmaculada C Palomo-Toucedo; Gabriel Domínguez-Maldonado; José Manuel Castillo-López; Javier Ramos-Ortega; Pedro V Munuera-Martínez Journal: BMJ Open Date: 2021-03-01 Impact factor: 2.692
Authors: Lara S Chapman; Anthony C Redmond; Karl B Landorf; Keith Rome; Anne-Maree Keenan; Robin Waxman; Begonya Alcacer-Pitarch; Heidi J Siddle; Michael R Backhouse Journal: J Foot Ankle Res Date: 2019-01-25 Impact factor: 2.303